ID MURA_ECOLI Reviewed; 419 AA. AC P0A749; P28909; Q2M923; DT 07-JUN-2005, integrated into UniProtKB/Swiss-Prot. DT 07-JUN-2005, sequence version 1. DT 24-JAN-2024, entry version 154. DE RecName: Full=UDP-N-acetylglucosamine 1-carboxyvinyltransferase {ECO:0000255|HAMAP-Rule:MF_00111}; DE EC=2.5.1.7 {ECO:0000255|HAMAP-Rule:MF_00111}; DE AltName: Full=Enoylpyruvate transferase {ECO:0000255|HAMAP-Rule:MF_00111}; DE AltName: Full=UDP-N-acetylglucosamine enolpyruvyl transferase {ECO:0000255|HAMAP-Rule:MF_00111}; DE Short=EPT {ECO:0000255|HAMAP-Rule:MF_00111}; GN Name=murA {ECO:0000255|HAMAP-Rule:MF_00111}; Synonyms=murZ; GN OrderedLocusNames=b3189, JW3156; OS Escherichia coli (strain K12). OC Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales; OC Enterobacteriaceae; Escherichia. OX NCBI_TaxID=83333; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 1-10, FUNCTION, RP CATALYTIC ACTIVITY, AND PATHWAY. RC STRAIN=K12 / AB1157; RX PubMed=1512209; DOI=10.1128/jb.174.17.5748-5752.1992; RA Marquardt J.L., Siegele D.A., Kolter R., Walsh C.T.; RT "Cloning and sequencing of Escherichia coli murZ and purification of its RT product, a UDP-N-acetylglucosamine enolpyruvyl transferase."; RL J. Bacteriol. 174:5748-5752(1992). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=O26 / NGY47; RX PubMed=10103182; DOI=10.1128/aac.43.4.789; RA Horii T., Kimura T., Sato K., Shibayama K., Ohta M.; RT "Emergence of fosfomycin-resistant isolates of Shiga-like toxin-producing RT Escherichia coli O26."; RL Antimicrob. Agents Chemother. 43:789-793(1999). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / MG1655 / ATCC 47076; RX PubMed=9278503; DOI=10.1126/science.277.5331.1453; RA Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V., RA Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F., RA Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B., RA Shao Y.; RT "The complete genome sequence of Escherichia coli K-12."; RL Science 277:1453-1462(1997). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911; RX PubMed=16738553; DOI=10.1038/msb4100049; RA Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S., RA Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.; RT "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 RT and W3110."; RL Mol. Syst. Biol. 2:E1-E5(2006). RN [5] RP ACTIVITY REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=21445328; DOI=10.1371/journal.pbio.1001033; RA Mutschler H., Gebhardt M., Shoeman R.L., Meinhart A.; RT "A novel mechanism of programmed cell death in bacteria by toxin-antitoxin RT systems corrupts peptidoglycan synthesis."; RL PLoS Biol. 9:E1001033-E1001033(2011). RN [6] {ECO:0007744|PDB:1UAE} RP X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH RP UDP-N-ACETYLGLUCOSAMINE AND FOSFOMYCIN, AND ACTIVE SITE. RX PubMed=8994972; DOI=10.1016/s0969-2126(96)00153-0; RA Skarzynski T., Mistry A., Wonacott A., Hutchinson S.E., Kelly V.A., RA Duncan K.; RT "Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme RT essential for the synthesis of bacterial peptidoglycan, complexed with RT substrate UDP-N-acetylglucosamine and the drug fosfomycin."; RL Structure 4:1465-1474(1996). RN [7] {ECO:0007744|PDB:1A2N} RP X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH FLUORINATED ANALOG OF RP THE REACTION TETRAHEDRAL INTERMEDIATE. RX PubMed=9485407; DOI=10.1021/bi9722608; RA Skarzynski T., Kim D.H., Lees W.J., Walsh C.T., Duncan K.; RT "Stereochemical course of enzymatic enolpyruvyl transfer and catalytic RT conformation of the active site revealed by the crystal structure of the RT fluorinated analogue of the reaction tetrahedral intermediate bound to the RT active site of the C115A mutant of MurA."; RL Biochemistry 37:2572-2577(1998). RN [8] {ECO:0007744|PDB:3KQJ, ECO:0007744|PDB:3KR6} RP X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) IN COMPLEX WITH RP UDP-N-ACETYLGLUCOSAMINE AND FOSFOMYCIN, FUNCTION, CATALYTIC ACTIVITY, RP ACTIVITY REGULATION, AND ACTIVE SITE. RX PubMed=20392080; DOI=10.1021/bi100365b; RA Han H., Yang Y., Olesen S.H., Becker A., Betzi S., Schoenbrunn E.; RT "The fungal product terreic acid is a covalent inhibitor of the bacterial RT cell wall biosynthetic enzyme UDP-N-acetylglucosamine 1- RT carboxyvinyltransferase (MurA)."; RL Biochemistry 49:4276-4282(2010). RN [9] {ECO:0007744|PDB:3SWD} RP X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 1-418 IN COMPLEX WITH SUBSTRATE RP ANALOG, ACTIVE SITE, AND FORMATION OF COVALENT REACTION INTERMEDIATE. RX PubMed=22378791; DOI=10.1074/jbc.m112.342725; RA Zhu J.Y., Yang Y., Han H., Betzi S., Olesen S.H., Marsilio F., RA Schoenbrunn E.; RT "Functional consequence of covalent reaction of phosphoenolpyruvate with RT UDP-N-acetylglucosamine 1-carboxyvinyltransferase (MurA)."; RL J. Biol. Chem. 287:12657-12667(2012). CC -!- FUNCTION: Cell wall formation (PubMed:1512209). Adds enolpyruvyl to CC UDP-N-acetylglucosamine (PubMed:1512209, PubMed:20392080). Target for CC the antibiotic fosfomycin. {ECO:0000269|PubMed:1512209, CC ECO:0000269|PubMed:20392080}. CC -!- CATALYTIC ACTIVITY: CC Reaction=phosphoenolpyruvate + UDP-N-acetyl-alpha-D-glucosamine = CC phosphate + UDP-N-acetyl-3-O-(1-carboxyvinyl)-alpha-D-glucosamine; CC Xref=Rhea:RHEA:18681, ChEBI:CHEBI:43474, ChEBI:CHEBI:57705, CC ChEBI:CHEBI:58702, ChEBI:CHEBI:68483; EC=2.5.1.7; CC Evidence={ECO:0000255|HAMAP-Rule:MF_00111, CC ECO:0000269|PubMed:1512209, ECO:0000269|PubMed:20392080}; CC -!- ACTIVITY REGULATION: Competitively inhibited by UDP-N-acetylglucosamine CC 3'-phosphate, with a Ki of 7 uM (PubMed:21445328). In vitro inhibited CC by covalent binding of fosfomycin and the fungal product terreic acid CC in the presence of substrate UDP-N-acetylglucosamine, with an CC inactivation rate constant of 102 M(-1)sec(-1) for terreic acid CC (PubMed:20392080). {ECO:0000269|PubMed:20392080, CC ECO:0000269|PubMed:21445328}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=15 uM for UDP-N-acetylglucosamine {ECO:0000269|PubMed:21445328}; CC -!- PATHWAY: Cell wall biogenesis; peptidoglycan biosynthesis. CC {ECO:0000255|HAMAP-Rule:MF_00111, ECO:0000269|PubMed:1512209}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00111, CC ECO:0000305}. CC -!- SIMILARITY: Belongs to the EPSP synthase family. MurA subfamily. CC {ECO:0000255|HAMAP-Rule:MF_00111}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M92358; AAA24187.1; -; Genomic_DNA. DR EMBL; U18997; AAA57990.1; -; Genomic_DNA. DR EMBL; U00096; AAC76221.1; -; Genomic_DNA. DR EMBL; AP009048; BAE77233.1; -; Genomic_DNA. DR EMBL; AB028039; BAA78107.1; -; Genomic_DNA. DR PIR; A44917; A44917. DR RefSeq; NP_417656.1; NC_000913.3. DR RefSeq; WP_000357259.1; NZ_STEB01000012.1. DR PDB; 1A2N; X-ray; 2.80 A; A=1-419. DR PDB; 1UAE; X-ray; 1.80 A; A=1-419. DR PDB; 2Z2C; X-ray; 2.05 A; A/B/C/D=1-419. DR PDB; 3ISS; X-ray; 2.50 A; A/B/C/D/E/F/G/H/I/J/K/L=1-418. DR PDB; 3KQJ; X-ray; 1.70 A; A=1-419. DR PDB; 3KR6; X-ray; 1.70 A; A=1-419. DR PDB; 3SWD; X-ray; 2.50 A; A/B/C/D/E/F/G/H/I/J/K/L=1-418. DR PDB; 5VM7; EM; 5.70 A; B=1-419. DR PDBsum; 1A2N; -. DR PDBsum; 1UAE; -. DR PDBsum; 2Z2C; -. DR PDBsum; 3ISS; -. DR PDBsum; 3KQJ; -. DR PDBsum; 3KR6; -. DR PDBsum; 3SWD; -. DR PDBsum; 5VM7; -. DR AlphaFoldDB; P0A749; -. DR SMR; P0A749; -. DR BioGRID; 4262438; 644. DR BioGRID; 852016; 3. DR DIP; DIP-48060N; -. DR IntAct; P0A749; 25. DR STRING; 511145.b3189; -. DR BindingDB; P0A749; -. DR ChEMBL; CHEMBL1984; -. DR DrugBank; DB00828; Fosfomycin. DR DrugCentral; P0A749; -. DR jPOST; P0A749; -. DR PaxDb; 511145-b3189; -. DR EnsemblBacteria; AAC76221; AAC76221; b3189. DR GeneID; 75173363; -. DR GeneID; 947703; -. DR KEGG; ecj:JW3156; -. DR KEGG; eco:b3189; -. DR PATRIC; fig|1411691.4.peg.3542; -. DR EchoBASE; EB1333; -. DR eggNOG; COG0766; Bacteria. DR HOGENOM; CLU_027387_0_0_6; -. DR InParanoid; P0A749; -. DR OMA; CDPHRAT; -. DR PhylomeDB; P0A749; -. DR BioCyc; EcoCyc:UDPNACETYLGLUCOSAMENOLPYRTRANS-MONOMER; -. DR BioCyc; MetaCyc:UDPNACETYLGLUCOSAMENOLPYRTRANS-MONOMER; -. DR BRENDA; 2.5.1.7; 2026. DR SABIO-RK; P0A749; -. DR UniPathway; UPA00219; -. DR EvolutionaryTrace; P0A749; -. DR PRO; PR:P0A749; -. DR Proteomes; UP000000318; Chromosome. DR Proteomes; UP000000625; Chromosome. DR GO; GO:0005829; C:cytosol; IDA:EcoCyc. DR GO; GO:0008760; F:UDP-N-acetylglucosamine 1-carboxyvinyltransferase activity; IDA:EcoCyc. DR GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW. DR GO; GO:0051301; P:cell division; IEA:UniProtKB-KW. DR GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW. DR GO; GO:0009252; P:peptidoglycan biosynthetic process; IMP:EcoCyc. DR GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW. DR GO; GO:0019277; P:UDP-N-acetylgalactosamine biosynthetic process; IEA:InterPro. DR CDD; cd01555; UdpNAET; 1. DR Gene3D; 3.65.10.10; Enolpyruvate transferase domain; 2. DR HAMAP; MF_00111; MurA; 1. DR InterPro; IPR001986; Enolpyruvate_Tfrase_dom. DR InterPro; IPR036968; Enolpyruvate_Tfrase_sf. DR InterPro; IPR013792; RNA3'P_cycl/enolpyr_Trfase_a/b. DR InterPro; IPR005750; UDP_GlcNAc_COvinyl_MurA. DR NCBIfam; TIGR01072; murA; 1. DR PANTHER; PTHR43783; UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE; 1. DR PANTHER; PTHR43783:SF1; UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE; 1. DR Pfam; PF00275; EPSP_synthase; 1. DR SUPFAM; SSF55205; EPT/RTPC-like; 1. PE 1: Evidence at protein level; KW 3D-structure; Cell cycle; Cell division; Cell shape; KW Cell wall biogenesis/degradation; Cytoplasm; Direct protein sequencing; KW Peptidoglycan synthesis; Pyruvate; Reference proteome; Transferase. FT CHAIN 1..419 FT /note="UDP-N-acetylglucosamine 1-carboxyvinyltransferase" FT /id="PRO_0000178870" FT ACT_SITE 115 FT /note="Proton donor" FT /evidence="ECO:0000269|PubMed:20392080, FT ECO:0000269|PubMed:8994972, ECO:0000305|PubMed:22378791, FT ECO:0007744|PDB:1UAE, ECO:0007744|PDB:3KR6" FT BINDING 22..23 FT /ligand="phosphoenolpyruvate" FT /ligand_id="ChEBI:CHEBI:58702" FT /evidence="ECO:0000305|PubMed:20392080, FT ECO:0000305|PubMed:22378791, ECO:0007744|PDB:3KR6, FT ECO:0007744|PDB:3SWD" FT BINDING 91 FT /ligand="UDP-N-acetyl-alpha-D-glucosamine" FT /ligand_id="ChEBI:CHEBI:57705" FT /evidence="ECO:0000269|PubMed:20392080, FT ECO:0007744|PDB:3KR6" FT BINDING 120..124 FT /ligand="UDP-N-acetyl-alpha-D-glucosamine" FT /ligand_id="ChEBI:CHEBI:57705" FT /evidence="ECO:0000269|PubMed:20392080, FT ECO:0000269|PubMed:22378791, ECO:0007744|PDB:3KR6" FT BINDING 160..163 FT /ligand="UDP-N-acetyl-alpha-D-glucosamine" FT /ligand_id="ChEBI:CHEBI:57705" FT /evidence="ECO:0000269|PubMed:20392080, FT ECO:0000269|PubMed:22378791, ECO:0007744|PDB:3KR6" FT BINDING 305 FT /ligand="UDP-N-acetyl-alpha-D-glucosamine" FT /ligand_id="ChEBI:CHEBI:57705" FT /evidence="ECO:0000269|PubMed:20392080, FT ECO:0000269|PubMed:22378791, ECO:0007744|PDB:3KR6" FT BINDING 327 FT /ligand="UDP-N-acetyl-alpha-D-glucosamine" FT /ligand_id="ChEBI:CHEBI:57705" FT /evidence="ECO:0000269|PubMed:20392080, FT ECO:0007744|PDB:3KR6" FT MOD_RES 115 FT /note="2-(S-cysteinyl)pyruvic acid O-phosphothioketal" FT /evidence="ECO:0000305|PubMed:22378791" FT STRAND 3..8 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 14..17 FT /evidence="ECO:0007829|PDB:3KQJ" FT HELIX 22..31 FT /evidence="ECO:0007829|PDB:3KQJ" FT HELIX 32..34 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 35..37 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 39..43 FT /evidence="ECO:0007829|PDB:3KQJ" FT HELIX 48..59 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 63..65 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 70..73 FT /evidence="ECO:0007829|PDB:3KQJ" FT HELIX 74..76 FT /evidence="ECO:0007829|PDB:2Z2C" FT HELIX 84..87 FT /evidence="ECO:0007829|PDB:3KQJ" FT HELIX 92..96 FT /evidence="ECO:0007829|PDB:3KQJ" FT HELIX 97..104 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 105..110 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 115..118 FT /evidence="ECO:0007829|PDB:3SWD" FT HELIX 123..131 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 135..139 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 142..146 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 148..150 FT /evidence="ECO:0007829|PDB:2Z2C" FT STRAND 155..157 FT /evidence="ECO:0007829|PDB:3KQJ" FT HELIX 163..173 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 176..184 FT /evidence="ECO:0007829|PDB:3KQJ" FT HELIX 189..200 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 204..206 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 210..216 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 224..227 FT /evidence="ECO:0007829|PDB:3KQJ" FT HELIX 232..245 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 248..253 FT /evidence="ECO:0007829|PDB:3KQJ" FT HELIX 256..258 FT /evidence="ECO:0007829|PDB:3KQJ" FT HELIX 260..268 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 272..275 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 277..283 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 293..295 FT /evidence="ECO:0007829|PDB:2Z2C" FT HELIX 304..306 FT /evidence="ECO:0007829|PDB:3KQJ" FT HELIX 307..316 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 317..324 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 326..328 FT /evidence="ECO:0007829|PDB:3ISS" FT TURN 329..333 FT /evidence="ECO:0007829|PDB:2Z2C" FT HELIX 334..339 FT /evidence="ECO:0007829|PDB:3KQJ" FT TURN 340..342 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 344..348 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 351..355 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 364..366 FT /evidence="ECO:0007829|PDB:3KQJ" FT HELIX 370..382 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 383..390 FT /evidence="ECO:0007829|PDB:3KQJ" FT HELIX 392..397 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 399..401 FT /evidence="ECO:0007829|PDB:3ISS" FT HELIX 402..408 FT /evidence="ECO:0007829|PDB:3KQJ" FT STRAND 412..417 FT /evidence="ECO:0007829|PDB:3KQJ" SQ SEQUENCE 419 AA; 44818 MW; 6B75A842255E53F7 CRC64; MDKFRVQGPT KLQGEVTISG AKNAALPILF AALLAEEPVE IQNVPKLKDV DTSMKLLSQL GAKVERNGSV HIDARDVNVF CAPYDLVKTM RASIWALGPL VARFGQGQVS LPGGCTIGAR PVDLHISGLE QLGATIKLEE GYVKASVDGR LKGAHIVMDK VSVGATVTIM CAATLAEGTT IIENAAREPE IVDTANFLIT LGAKISGQGT DRIVIEGVER LGGGVYRVLP DRIETGTFLV AAAISRGKII CRNAQPDTLD AVLAKLRDAG ADIEVGEDWI SLDMHGKRPK AVNVRTAPHP AFPTDMQAQF TLLNLVAEGT GFITETVFEN RFMHVPELSR MGAHAEIESN TVICHGVEKL SGAQVMATDL RASASLVLAG CIAEGTTVVD RIYHIDRGYE RIEDKLRALG ANIERVKGE //